Male Fertility Global Market Report 2024

The male fertility market size has grown strongly in recent years. It will grow from $3.74 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to changing lifestyles and habits, environmental factors, advancements in medical technology, increasing awareness and acceptance of male fertility issues, socioeconomic factors.

The male fertility market size is expected to see steady growth in the next few years. It will grow to $4.76 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to aging population, rising prevalence of male fertility disorders, growing demand for assisted reproductive technologies, expanding access to fertility treatments, increasing research and development in male fertility solutions. Major trends in the forecast period include personalized medicine in male fertility treatments, integration of artificial intelligence and big data analytics in diagnosis and treatment, shift towards natural and holistic approaches to improve male fertility, telemedicine and remote monitoring for fertility consultations, emphasis on mental health and stress management in male fertility care.

The increasing funding for fertility research is expected to propel the growth of the male fertility market going forward. Fertility research encompasses the scientific investigation and study of factors influencing reproductive health, including but not limited to conception, pregnancy, and the optimization of fertility outcomes. Funding for fertility research prioritizes investigations into male fertility to comprehensively understand reproductive health, improve overall fertility outcomes, and address the significant role that male factors play in conception and reproductive success. For instance, in October 2023, according to the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a US-based health department, granted $2.26 million to study fertility-sparing treatments. Further, in September 2022, the Medical Research Future Fund (MRFF), an Australia-based medical research organization, awarded a total of $3.3 million in grants to support endometriosis sufferers, search for fertility options, and improve clinical registries. Therefore, the increasing funding for fertility research is driving the growth of the male fertility market.

Major companies operating in the male fertility market are focusing on innovation in services such as testing services to help people access information about their fertility, allowing them to take greater control of their reproductive health. A testing service is a service that provides testing or analysis of a particular substance or condition. For instance, in November 2022, Superdrug Stores plc, a UK-based retail company, launched the UK's first male fertility service on the high street. The testing service consists of a clinical-grade sperm test, comparable to a World Health Organization or NHS test, and is accepted by most fertility treatments. The services also offer clinical-grade semen analysis that uses 'state-of-the- art’ AI microscopes. Results analyze 22 different parameters, including morphology - the size and shape of sperm. The discreet, at-home test kit can be picked up in store and taken home. The sample will then be picked up by a courier, and results will be available 48 hours after the lab receives them. A full diagnostic report will be provided, which can be used for onward referrals or reviews with a fertility specialist.

In March 2022, Ro, a US-based digital health company, acquired Dadi for an undisclosed amount. With this acquisition, Ro aims to expand its fertility offerings and make these services more accessible, convenient, and affordable. Dadi is a US-based fertility company specializing in sperm testing, analysis, and storage.

Major companies operating in the male fertility market report are Bayer Healthcare Inc., Sanofi S.A., MERCK KGaA, Essity AB, Laboratory Corporation Of America Holdings, Endo International plc., Cook Medical, Zydus Lifesciences Ltd., Intas Pharmaceuticals Ltd., ASKA Pharmaceutical Co. Ltd, EMD Serono Inc., Dendreon Pharmaceuticals LLC, Vitrolife, CinnaGen Co., Aytu BioScience Inc., Kindbody, Cryos International, AdvaCare Pharma USA, Ferring Pharmaceuticals, Apricus Biosciences, Reprotech Ltd., Vios Fertility Institute, Andrology Solutions, DxNow, Epicypher, INVO Bioscience.

North America was the largest region in the male fertility market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the male fertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the male fertility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The male fertility market includes revenues earned by entities by diagnostic testing services, fertility consultations and counselling, fertility treatments and therapies or sperm banking and storage services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Male fertility is commonly defined as the capability of a man to impregnate his female partner. It involves a complex process reliant on the production of healthy sperm, the proper functioning of male reproductive organs, and the ability to achieve an erection and ejaculate, facilitating the sperm's journey to reach the egg.

In the realm of male fertility testing, various test types are employed, including sperm agglutination, DNA fragmentation analysis, oxidative stress analysis, computer-assisted semen analysis, sperm penetration assay, and other diagnostic methods. Sperm agglutination refers to the clustering of sperm cells, often caused by the presence of antibodies on the sperm cell surface or in the surrounding seminal fluid. Treatment options for male fertility issues typically involve assisted reproductive technology, varicocele surgery, and medication. Medications may include antioxidants, vitamins, minerals, amino acids, and enzymes. These treatments are administered in hospitals, clinics, fertility centers, research institutes, and other end-user settings.

The male fertility market research report is one of a series of new reports that provides male fertility market statistics, including male fertility industry global market size, regional shares, competitors with male fertility market share, detailed male fertility market segments, market trends, and opportunities, and any further data you may need to thrive in the male fertility industry. This male fertility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.